IFG
MIRM icon

Independent Financial Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Independent Financial Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,300
Closed -$225K – 814
2021
Q3 		$225K Buy
+11,300
New +$184K 0.02% 631

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Independent Financial Group's MIRM Position: Q4 2021 in Review

Independent Financial Group sold out of Mirum Pharmaceuticals (MIRM) in Q4 2021, closing a stake of 11,300 shares — an estimated $225K sold.

Independent Financial Group first reported a position in MIRM in Q3 2021 and held it in 1 quarter. The position peaked at $225K in Q3 2021. 86 funds tracked by Wall St. Rank hold MIRM as of Q4 2021.

  • Independent Financial Group reported no remaining Mirum Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Independent Financial Group sold 11,300 Mirum Pharmaceuticals shares in Q4 2021, an estimated $225K.
  • Independent Financial Group first reported a position in Mirum Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Independent Financial Group's Mirum Pharmaceuticals position peaked at $225K in Q3 2021.
  • 86 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2021.

Based on Independent Financial Group's 13F filing for Q4 2021, filed 15 Jun 2026.